MERCOSUR - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingMERCOSUR: Medicaments Containing Insulin Market 2024
Medicaments Containing Insulin Market Size in MERCOSUR
In 2023, the MERCOSUR medicaments containing insulin market was finally on the rise to reach $X after four years of decline. Over the period under review, consumption, however, continues to indicate a pronounced downturn. The level of consumption peaked at $X in 2015; however, from 2016 to 2023, consumption stood at a somewhat lower figure.
Medicaments Containing Insulin Production in MERCOSUR
In value terms, medicaments containing insulin production stood at $X in 2023 estimated in export price. Overall, production, however, saw a perceptible decrease. The pace of growth appeared the most rapid in 2013 with an increase of X%. As a result, production reached the peak level of $X. From 2014 to 2023, production growth failed to regain momentum.
Medicaments Containing Insulin Exports
Exports in MERCOSUR
In 2023, medicaments containing insulin exports in MERCOSUR shrank remarkably to X tons, waning by X% on 2022. Over the period under review, exports, however, showed tangible growth. The growth pace was the most rapid in 2022 when exports increased by X%. The volume of export peaked at X tons in 2017; however, from 2018 to 2023, the exports stood at a somewhat lower figure.
In value terms, medicaments containing insulin exports shrank sharply to $X in 2023. Overall, exports saw a abrupt decrease. The most prominent rate of growth was recorded in 2022 with an increase of X%. The level of export peaked at $X in 2017; however, from 2018 to 2023, the exports failed to regain momentum.
Exports by Country
In 2023, Brazil (X tons) represented the largest exporter of medicaments containing insulin but not antibiotics in MERCOSUR, generating X% of total export.
Brazil was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics exports, with a CAGR of X% from 2012 to 2023. While the share of Brazil (X p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.
In value terms, Brazil ($X) also remains the largest medicaments containing insulin supplier in MERCOSUR.
From 2012 to 2023, the average annual rate of growth in terms of value in Brazil totaled X%.
Export Prices by Country
In 2023, the export price in MERCOSUR amounted to $X per ton, approximately equating the previous year. Overall, the export price, however, showed a abrupt setback. The most prominent rate of growth was recorded in 2013 an increase of X%. As a result, the export price attained the peak level of $X per ton. From 2014 to 2023, the export prices remained at a lower figure.
As there is only one major export destination, the average price level is determined by prices for Brazil.
From 2012 to 2023, the rate of growth in terms of prices for Brazil amounted to X% per year.
Medicaments Containing Insulin Imports
Imports in MERCOSUR
In 2023, supplies from abroad of medicaments containing insulin but not antibiotics increased by X% to X tons, rising for the second year in a row after three years of decline. In general, imports saw a relatively flat trend pattern. The growth pace was the most rapid in 2018 when imports increased by X% against the previous year. As a result, imports reached the peak of X tons. From 2019 to 2023, the growth of imports failed to regain momentum.
In value terms, medicaments containing insulin imports expanded rapidly to $X in 2023. Over the period under review, imports, however, showed a abrupt decline. The growth pace was the most rapid in 2013 when imports increased by X%. Over the period under review, imports attained the peak figure at $X in 2015; however, from 2016 to 2023, imports remained at a lower figure.
Imports by Country
Brazil prevails in imports structure, reaching X tons, which was approx. X% of total imports in 2023. Uruguay (X kg) held a X% share (based on physical terms) of total imports, which put it in second place, followed by Guyana (X%). Venezuela (X kg) took a little share of total imports.
From 2012 to 2023, average annual rates of growth with regard to medicaments containing insulin imports into Brazil stood at X%. At the same time, Guyana (X%) and Uruguay (X%) displayed positive paces of growth. Moreover, Guyana emerged as the fastest-growing importer imported in MERCOSUR, with a CAGR of X% from 2012-2023. By contrast, Venezuela (X%) illustrated a downward trend over the same period. Brazil (X p.p.) and Guyana (X p.p.) significantly strengthened its position in terms of the total imports, while Venezuela saw its share reduced by X% from 2012 to 2023, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.
In value terms, Brazil ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in MERCOSUR, comprising X% of total imports. The second position in the ranking was held by Venezuela ($X), with a X% share of total imports. It was followed by Uruguay, with a X% share.
From 2012 to 2023, the average annual rate of growth in terms of value in Brazil stood at X%. In the other countries, the average annual rates were as follows: Venezuela (X% per year) and Uruguay (X% per year).
Import Prices by Country
The import price in MERCOSUR stood at $X per ton in 2023, with an increase of X% against the previous year. In general, the import price, however, continues to indicate a deep reduction. The growth pace was the most rapid in 2014 when the import price increased by X% against the previous year. As a result, import price attained the peak level of $X per ton. From 2015 to 2023, the import prices failed to regain momentum.
Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Venezuela ($X per ton), while Brazil ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Venezuela (X%), while the other leaders experienced a decline in the import price figures.
Source: IndexBox Platform
This report provides an in-depth analysis of the medicaments containing insulin market in MERCOSUR. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale
Country coverage:
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Production in MERCOSUR, split by region and country
- Trade (exports and imports) in MERCOSUR
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- CONSUMPTION BY COUNTRY
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
- PRODUCTION BY COUNTRY
8. IMPORTS
The Largest Importers on The Market and How They Succeed
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Exporters on The Market and How They Succeed
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
11. COUNTRY PROFILES
The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO- Argentina
- Brazil
- Chile
- Colombia
- Ecuador
- Guyana
- Paraguay
- Peru
- Suriname
- Uruguay
- Venezuela
-
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption, By Country, 2018–2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Destination, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Origin, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Consumption, By Country, 2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Production, By Country, 2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, 2012–2023
Recommended reports
This report provides an in-depth analysis of the medicaments containing insulin market in Asia.
This report provides an in-depth analysis of the medicaments containing insulin market in the U.S..
This report provides an in-depth analysis of the medicaments containing insulin market in China.
This report provides an in-depth analysis of the medicaments containing insulin market in the EU.
This report provides an in-depth analysis of the global medicaments containing insulin market.